1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsBiotech Innovation Path Call is sponsored by EIT Health. This call is for innovation projects related to biotechnology.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Biotech Certified Innovation Path Home |  Events & Opportunities |  Biotech Certified Innovation Path Biotech Certified Innovation Path EIT Health invites organisations from industry, education and research to submit proposals for the development of a new EIT Label-certified Biotech pathway within the Certified Innovation Path (CIP) portfolio, complementing the existing Health Data, Digital Medical Devices and High Value Care pathways.
Funded projects will design and deliver personalised learning courses for graduates and professionals across the health biotechnology value chain. The pathway will equip participants with the innovation, entrepreneurship and biotech expertise needed to translate scientific advances into scalable, market-ready healthcare solutions across Europe.
The call information and supporting documents are now available to help applicants prepare their proposals. Access to the application platform will open on 15 July 2026 .
A consortium of minimum two Higher Education Institutions (HEIs) established in two different eligible Member States, of which: At least one HEI must be established in an EIT RIS region; and At least one of the participating Higher Education Institutions must be authorised to award ECTS credits for the repurposed courses.
At least one non-academic or industry partner, expected to actively contribute to the curriculum of the repurposed courses and to the supervision of learner assessment. Active and substantive involvement of non-academic or industry partners is essential, as a highly integrated, innovative learning by doing approach is a core principle of EIT Labelled Fellowships.
Learners are expected to work both individually and in interdisciplinary teams, typically addressing authentic challenges articulated by industry and other non-academic partners. Proposed courses must aim to: Equip participants to navigate and apply Europe’s evolving regulatory and policy landscape, including the EU Biotech Act, Clinical Trials Regulation and MDR/IVDR, with a focus on translation and early scaleup.
Integrate advanced biotech and translational expertise with EIT Labelled innovation, entrepreneurship and leadership competencies, enabling real-world implementation of biotech innovation. Strengthen cross border collaboration, mobility and industry engagement, connecting European research, clinical, manufacturing and investment ecosystems through applied learning and capstone projects.
Enable participants to articulate and demonstrate projected scientific, clinical and economic value across development stages, and to align development strategies with financing, partnering and market access considerations.
Up to 240 000 € per awarded project Graduates from EIT-labelled programmes: 150 CIP graduates by 2028 – Across all pathways EIT RIS Graduates from EIT labelled programmes: 30 CIP graduates by 2028 – 20% of graduates) Call opens on: 24 June 2026 Call closes on: 16 September 2026 Evaluation Period: 16 September 2026 – 29 October 2026 Open Q&A Session: 03 September 2026 – 11:00 CET – Register here Final Award Notification: 11 November 2026 Project Start Date: 01 January 2026 Click here for the official call document and supporting documents Step 1: Register your organisation in the EU Funding & tender opportunities portal to obtain the nine-digit Participant Identification Code (PIC number).
If you do not know if your organisation already has a PIC number, you can verify directly on the EU Portal whether your organisation is already registered. Step 2: Apply to the call via EIT Health’s application platform. Click on the “Apply” button below.
According to the current listing, eligibility includes: Not specified in detail, but generally targets early-stage startups (pre-seed to Series A) with a prototype, pilot or MVP, established in an EU Member State or Horizon Europe-associated country, operating within EIT Hea…. Confirm the full requirements in the official notice before applying.
The published deadline was September 16, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Biotech Innovation Path Call is funded by EIT Health. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The Gates Foundation committed at least $1 billion over two years to equitable AI alongside its 10th Goalkeepers Report — 40% education, 40% health, 10% agriculture, 10% digital infrastructure. Five days later, 60 organizations signed a five-year goal to reach 3.4 billion speakers of underrepresented languages. Here is how implementing nonprofits should read both.
Read articleThe Health and Extreme Weather highlighted topic went live September 1, 2026 with eleven awarding institutes and expires May 1, 2028. There is no set-aside, no separate deadline, and no review criteria — which makes the institute-by-institute language the only real signal, and it is not uniform.
Read articleThe NOURISH Autoimmunity Digital Health Challenge runs three phases to August 2028: 10 winners at $20,000, then 5 at $30,000, then 3 at $100,000. It is a prize competition, not a grant — no indirect costs, no cost reimbursement, and a rule that quietly disqualifies the obvious applicant.
Read article